Kite Pharma Competitors and Similar CompaniesClear all
G1 Therapeutics's competitors and similar companies include Amgen.
 G1 Therapeutics G1 Therapeutics is a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. | |
Founding Date | Founding Date 2008 | Founding Date 1980 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Durham, US HQ | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more |
Employees | Employees 17015% increase | Employees 25,200 |
Valuation ($) | Valuation ($) 377.2 m | Valuation ($) 170.4 b |
Financial | ||
Revenue (est.) | Revenue (est.) $82.5m (FY, 2023) | Revenue (est.) $36.8b (FY, 2025) |
Cost of goods | Cost of goods $7.2m (FY, 2023) | Cost of goods $12b (FY, 2025) |
Gross profit | Gross profit $75.3m (FY, 2023) | Gross profit $24.7b (FY, 2025) |
Net income | Net income ($48m) (FY, 2023) | Net income $7.7b (FY, 2025) |
Operating ⚠ | ||
Patents (US) | Patents (US) 40 (FY, 2020) | Patents (US) 31 (FY, 2020) |
For sources of this data, please see the company profile
View Company Profiles
Amgen
HQ
Thousand Oaks, US
Employees
25,200
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View company